Send me a link:

*Text messaging rates may apply.

 Dow Down 0.72% Nasdaq Down 0.50%

Arrowhead Research Corp. (ARWR)

-NasdaqGS
11.24 Down 0.20(1.75%) Jul 25, 4:00PM EDT
|After Hours : 11.24 0.00 (0.00%) Jul 25, 4:46PM EDT
Prev Close:11.44
Open:11.36
Bid:11.00 x 500
Ask:11.29 x 500
1y Target Est:28.10
Beta:2.84
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:11.09 - 11.38
52wk Range:3.10 - 27.63
Volume:775,502
Avg Vol (3m):1,885,270
Market Cap:583.04M
P/E (ttm):N/A
EPS (ttm):-1.20
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARWRDown 1.75%583.04M
APNT 0.00%6.75M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3,390.97
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Sep-14) :-0.94
Quarterly EPS Est (Jun-14) :-0.22
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-1.44

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arrowhead Research Corporation, a biopharmaceutical company, develops targeted RNAi therapeutics in the United States. The company’s product candidate comprise ARC-520, an RNAi-based therapeutic that has completed a Phase 1 clinical trial for... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback